C50.111
Malignant neoplasm of central portion of right female breast
Clinical Classification Guidelines
Medical Intelligence & Overview
Malignant neoplasm of the central portion of the right female breast refers to breast cancer located centrally within the breast tissue on the right side. This type of cancer originates from the cells lining the milk ducts or lobules and has the potential to grow and spread if not diagnosed and treated early. Recognized under ICD-10 code C50.111, it highlights a specific location within the breast, aiding in precise diagnosis and treatment planning.
Causes & Symptoms
Clinical Causes: Genetic predispositions, such as BRCA1 or BRCA2 mutations Hormonal factors, including prolonged exposure to estrogen Lifestyle factors, such as alcohol consumption and obesity Radiation exposure or previous chest radiation treatments Personal or family history of breast cancer Age and hormonal changes associated with aging Environmental exposures to carcinogens
Key Symptoms: Lump or mass in the central part of the right breast Changes in the size, shape, or appearance of the breast Skin changes over the affected area, such as redness or dimpling Nipple abnormalities, including inversion or discharge Persistent pain or discomfort in the breast or nipple area Swelling or lumps in the armpit, indicating potential spread Unexplained weight loss or fatigue in advanced cases
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves a combination of clinical examinations, imaging studies, and tissue sampling. Common steps include: - Physical breast exam to detect abnormalities - Mammography tailored to investigate central breast regions - Ultrasound scans to assess the nature of a detected lump - Breast MRI for detailed imaging, especially in complex cases - Biopsy procedures (such as core needle biopsy) to obtain tissue samples for histological analysis - Additional tests may include genetic testing and blood work to evaluate overall health and cancer markers
Treatment Protocols: Management of malignant neoplasm of the central right breast typically involves a multidisciplinary approach, personalized to the tumor's characteristics and patient health. Treatment options may include: - Surgery: Options range from breast-conserving procedures like lumpectomy to mastectomy, depending on tumor size and spread - Radiation therapy to target residual cancer cells post-surgery - Chemotherapy to eliminate cancer cells systemically, especially if there’s a higher risk of spread - Hormone therapy for cancers that are hormone receptor-positive - Targeted therapy aimed at specific molecular features of the tumor - Supportive care to manage side effects and improve quality of life Regular follow-up and monitoring are crucial for assessing treatment effectiveness and early detection of potential recurrence.
Clinical Advice & FAQs
Billing Guidance
Is C50.111 a billable ICD-10 code?
Yes, C50.111 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C50.111?
Clinical documentation must specify the nature of Malignant neoplasm of central portion of right female breast and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
